相关实验视频
Updated: Jul 5, 2026

12:03
Myocardial Infarction and Functional Outcome Assessment in Pigs
Published on: April 25, 2014
与腺相比,静脉内和冠状腺5'-三酸盐对冠状动脉流量和压力动态的影响
A Jeremias1, S D Filardo, R J Whitbourn
1Division of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, CA, USA.
Circulation
|January 25, 2000
概括
腺三酸盐 (ATP) 相当于腺,用于通过冠状动脉流量储备 (CFR) 和分数流量储备 (FFR) 来评估冠状动脉狭窄. 然而,与完全的冠状动脉封闭相比,这两种药物都不会诱导最大的高血压.
科学领域:
- 心血管生理学心血管生理学
- 干预性心脏病学 干预性心脏病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 冠状动脉流量储备 (CFR) 和分量流量储备 (FFR) 的测量需要最大的高血压.
- 氨酸是标准的高血压诱导剂,但具有成本和耐受性等缺点.
研究的目的:
- 评估腺三酸盐 (ATP) 作为诱导高血压的腺的替代品.
- 为了比较ATP和腺在CFR和FFR测量的疗效.
主要方法:
- 在犬类和人类狭窄症中测试ATP和腺的等价性.
- 使用冠状动脉内ATP,腺和冠状动脉封闭来测量CFR和FFR.
- 对这两种药物的剂量反应评估.
主要成果:
- ATP和腺都显著增加了CFR和FFR,更高的剂量产生了更大的高血压.
- 在CFR (R=0.934) 和FFR (R=0.985) 中,ATP和腺素显示出极好的线性相关性.
- 对ATP和腺的高血压反应小于冠状动脉封闭所取得的反应.
结论:
- 增加ATP和腺的剂量会增加冠状动脉高血压,超过标准的临床建议.
- 在CFR和FFR评估中,ATP在治疗上相当于腺.
- 两种药物剂都没有达到最大的高血压;冠状动脉封闭提供了优异的高血压反应.
相关概念视频
Pathophysiology of Cardiac Performance
Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
Antianginal Drugs: Nitrates and β-Blockers
In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
Imaging Studies for Cardiovascular System V: CT
Cardiac computed tomography (CT) scanning is an advanced cardiac imaging technique that utilizes CT technology, with or without intravenous (IV) contrast, to produce accurate cross-sectional virtual slices of specific areas of the heart, coronary circulation, and major blood vessels such as the aorta, pulmonary veins, and arteries. The computer processes these slices to generate three-dimensional images. Multidetector CT (MDCT) is a rapid form of CT scanning that captures multiple slices...
Coronary Artery Disease V: Interprofessional Care
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome III: Diagnostic Studies
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Cardiopulmonary Resuscitation IV: Pharmacological Management
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...

